Glenmark Glenmark Pharmaceuticals Limited (GLENMARK) Q3 2026 Earnings Call Transcript 4 weeks ago Glenmark Pharmaceuticals Limited (NSE: GLENMARK) Q3 2026 Earnings Call dated Feb. 02, 2026 Corporate Participants: Glenn Saldanha — Chairman and… Glenmark Pharmaceuticals Q3 FY26 Revenue Rises 15.1% on Strong Domestic and North American Growth 4 weeks ago Glenmark Pharmaceuticals Ltd. (NSE: GLENMARK) reported consolidated revenue of ₹39,006 million for the third quarter ended December 31, 2025, a…